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This report highlights selected evidence of different cancer patterns among African Americans and whites and considers potential risk factors
associated with these cancers. During the years 1987 to 1991, African Americans experienced higher incidence and mortality rates than whites for
multiple myeloma and for cancers of the oropharynx, colorectum, lung and bronchus, cervix, and prostate. African Americans had lower incidence
and mortality for cancer of the urinary bladder. The incidence of breast cancer was higher among white women, but mortality was higher among
African American women. Five-year relative survival for the period 1983 to 1990 was generally lower among African Americans than whites for
cancers of the oropharynx, colorectum, cervix, prostate, and female breast but slightly higher for multiple myeloma. From 1973 to 1991, there were
significant declines in cervical cancer incidence among women of both races, oropharyngeal cancer mortality among whites, and bladder cancer
mortality for whites and African Americans. Risk factors for the more prominent cancers suggest that efforts aimed at changing lifestyles,
achieving socioeconomic parity, and insuring environmental equity are likely to relieve African Americans of much of their disproportionate cancer
burden. - Environ Health Perspect 103(Suppl 8):275-281 (1995)
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Introduction
Interest has intensified in recent years
regarding the variation of cancer incidence
and mortality among racial groups,
particularly among African Americans,
who comprise the largest racial minority
group in the United States (1). Particularly
germane are demographic changes, the lack
ofsubstantial gains against established can-
cers, and increasing evidence that higher
percentages ofAfrican Americans and
Hispanics than whites live in areas polluted
by potential environmental carcinogens
(2). Descriptive and analytic epidemiologic
studies have provided abundant information
concerning the African American commu-
nity's disproportionate cancer burden, a
burden that is marked by increasing mortal-
ity rates for many cancers in sharp contrast
to more favorable trends amongwhites (3).
During the period from 1987 to 1991,
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experienced higher incidence and mortality
rates than whites for multiple myeloma
and for cancers ofthe oropharynx, colorec-
tum, lung and bronchus, cervix, and
prostate, (Table 1). African Americans had
lower incidence and mortality for cancer of
the urinary bladder. The incidence of
breast cancer was higher among white
women, but mortality was higher among
African American women. Five-year relative
survival for the period 1983 to 1990 gener-
ally was lower among African Americans
than whites for cancers ofthe oropharynx,
colorectum, cervix, prostate, and female
breast, but slightly higher for multiple
myeloma. From 1973 to 1991, there were
significant declines in cervical cancer inci-
dence amongwomen ofboth races, oropha-
ryngeal cancer mortality amongwhites, and
bladder cancer mortality among both
whites andAfricanAmericans.
This report highlights selected cancer
sites and briefly considers some of the
potential risk factors investigated to explain
differences in incidence and mortality
among African Americans and whites.
More detailed discussions of risk factors
such as socioeconomic status (4-11) can
be found elsewhere.
Oral Cavity and Pharynx
The National Cancer Institute estimated
that there would be 29,600 new cases and
7925 deaths in 1994 attributable to cancer
ofthe oral cavity and pharynx, including
lip, salivary gland, and nasopharynx (Table
1) (3). African American men have the
highest incidence and mortality rates, and
the racial disparity has been increasing over
time. African American men are the only
racial/gender group to experience increases
in both incidence and mortality during the
1987 to 1991 period (3). In addition,
African American men have the poorest
5-yearsurvival rates forthesetypes ofcancer.
The primary risk factors for cancer of
the oral cavity and pharynx are alcohol and
tobacco consumption (12). Day et al. (12)
reported that differences in the relative
risks and prevalences ofexposure to alcohol
and tobacco account for most ofthe racial
variation. The interactions (multiplicative
effects) ofalcohol and tobacco were asso-
ciated with greater risk among African
Americans than whites. The reasons for
higher risks amongAfrican Americans who
consume alcohol than among white indi-
viduals who drink are not known, but may
be related to the types ofalcohol beverages
consumed. Other factors, such as diet, may
also play a role. Interventions aimed at
reducing alcohol and tobacco use represent
the best opportunities to prevent these can-
cers. Tobacco use trends suggest that inter-
ventions should target certain age groups
(Table 2).
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Table 1. Incidence, mortality, and survival for selected cancers in the United States among blacks and whites.
5-Year relative
Incidence per 105, % Change, Mortality per 105, % Change, survival rate,
1987-1991, 1973-1991, 1987-1991, 1973-1991, 1983-1990, 1994 Projected cancer burden
Cancertype Black/White Black/White Black/White Black/White Black/White New cases(% Deaths(%)
Oral cavity and pharynx
Male 23.7/15.8 38.3/-11.2 9.2/4.2 15.6/-27.3 28.5/52.5 19,800 (3) 5,150 (2)
Female 6.5/6.2 -0.6/-0.1 2.3/1.6 1.6/-13.2 47.1/59.1 9,800(2) 2,775 (1)
Colorectal
Male 60.9/58.7 36.1/3.0 28.0/23.3 25.1/-11.2 48.6/60.7 75,000 (12) 27,000(10)
Female 46.7/39.9 20.0/-6.6 20.6/15.6 3.8/-23.6 50.2/59.2 74,000 (13) 28,000(11)
Lung and bronchus
Male 122.4/80.7 15.8/7.9 105.5/73.9 38.2/17.1 10.6/12.1 100,000 (16) 94,000 (33)
Female 44.5/41.3 124.2/125.7 30.4/30.9 129.7/134.2 12.3/16.2 72,000 (13) 59,000 (23)
Breast
Female 94.0/113.2 30.3/25.8 31.2/27.2 20.2/0.6 65.8/81.6 182,000 (32) 46,000(18)
Cervix
Female 14.0/7.8 -57.1/-35.4 6.7/2.6 -48.2/-41.3 56.4/69.9 15,000 (3) 4,600 (2)
Prostate
Male 163.1/121.2 81.9/127.1 52.0/23.6 39.2/21.3 66.4/81.3 200,000 (32) 38,000 (13)
Bladder
Male 15.0/32.3 28.5/13.2 4.8/5.8 -14.3/-21.7 66.0/82.6 38,000 (6) 7,000 (2)
Female 5.9/7.8 33.9/13.0 2.4/1.6 -20.7/-19.6 48.7/75.2 13,000 (2) 3,600(1)
Multiple myeloma
Male 11.1/5.1 3.2/27.2 7.2/3.4 46.1/31.8 31.1/28.0 6,500(1) 5,000(2)
Female 7.7/3.3 9.2/-0.1 4.9/2.2 45.1/28.2 27.9/26.8 6,200 (1) 4,800(2)
All sites
Male 557.2/464.0 33.9/31.1 316.8/213.3 23.6/5.6 35.7/50.8 632,000 283,000
Female 331.8/348.0 17.7/15.0 166.9/139.6 13.3/8.1 45.5/59.8 576,000 255,000
aPercent of all cancer deaths forthatgender. From Reis et al. (3).
Table 2. Percent of persons 18 years old and over
currently smoking cigarettes by gender, race, and age,
United States, selected years 1979 to 1990.
Gender Year
and race Age 1979 1983 1987 1990
Men
White 18-24 34.3 32.5 29.2 27.4
25-34 43.6 38.6 33.8 31.6
35-44 41.3 40.8 36.2 33.5
45-54 38.3 35.0 32.4 28.7
.65 20.5 20.6 16.0 13.7
Black 18-24 40.2 34.2 24.9 21.3
25-34 47.5 39.9 44.9 33.8
35-44 48.6 45.5 44.0 42.0
45-54 50.0 44.8 44.3 36.7
.65 26.2 38.9 30.3 21.5
Women
White 18-24 34.5 36.5 27.8 25.4
25-34 34.1 32.2 31.9 28.5
35-44 37.2 34.8 29.2 25.0
45-54 30.6 30.6 29.0 25.4
.65 13.8 13.2 13.9 11.5
Black 18-24 31.8 32.0 20.4 10.0
25-34 35.2 38.0 35.8 29.1
35-44 37.7 32.7 35.3 25.5
45-54 34.2 36.3 28.4 22.6
.65 8.5 13.1 11.7 11.1
From Reis et al. (3).
Colorectal
Colorectal cancer is one of the nation's
most common malignancies, accounting
for one in every eight cancers in the United
States. In 1994, there were an estimated
149,000 new cases and 51,000 deaths asso-
ciated with colorectal cancer (3). African
Americans have greater incidence and mor-
tality from colorectal cancer than whites,
with the greatest racial differences occur-
ring among women. While incidence
declined among white women and mortal-
ity decreased among both white men and
women during the 1973 to 1991 period,
rates among African Americans rose. The
incidence of colorectal cancer increased
36.1% among African American men yet
only 3.0% among white men. Mortality
rose 25.1% among African American men
but decreased 11.2% among white men
during the same period. The disparities
increase with age. African Americans are
more likely to be diagnosed at a later stage
of disease than whites for both colon and
rectal cancers (13). The rate of survival is
worse for African Americans than for
whites and, in general, did not increase
during the years 1983 to 1990, a period
during in which survival rates among
whites improved.
Risk factors for colorectal cancer that
might explain some of the racial differ-
ences are diet, alcohol consumption,
physical activity, exogenous hormone
exposure, parity, genetic susceptibility,
cancer genotype, and smoking (14,15). A
combination of prevention regimes may
present the best opportunity to lower rates
among African Americans and reverse
diverging racial trends.
Lung
Lung cancer accounted for 14% ofall can-
cer cases and 28% of all cancer deaths in
the United States during 1994, with an
estimated 172,000 new cases and 153,000
deaths (Table 1) (3). African American
men have significantly higher incidence
and mortality rates than white men.
Tobacco use was recognized nearly 40
years ago as the leading risk factor for lung
cancer (16). Cigarette smoking patterns
explain some ofthe racial differences. With
the exception ofyoung women, African
Americans generally have higher smoking
rates than whites (Table 2). Recent investi-
gations ofgenetic polymorphisms and lung
cancer found no racial differences in the
prevalence of alleles for cytochrome P450
2E1 (17) but did find differences in allelic
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frequency for L-myc, p53, and CYPIAI
genes (18-20). Research regarding the role
ofthese genetic differences in lung cancer
etiology is under way. Socioeconomic fac-
tors may also explain some of the racial
variation in lung cancer (21). Differential
environmental and occupational exposures
may also may explain a portion ofthe lung
cancer excess. There is some evidence that
African Americans disproportionately reside
or work in areas exposed to industrial
chemicals (2,22).
Breast
Breast cancer is the most common invasive
cancer among women, representing 32% of
all new cancer cases and 18% of cancer
deaths in the United States (3). Since 1988,
breast cancer has been the leading cause of
death in the United States for women
between 40 and 55 years old. In 1994,
there were approximately 182,000 breast
cancer cases diagnosed and 46,300 deaths
(Table 1) (3). Although white women are
diagnosed more often with breast cancer
than African American women, mortality
rates are higher among African American
women. While there has been little to no
increase in breast cancer mortality among
whites, African American women have exp-
erienced a 20% increase from 1973 to 1991.
On average, African American women are
diagnosed in later stages than white women,
and have less improvement over time (23).
Age-specific, 5-year relative survival rates are
nearly 15% lower among African American
women than whitewomen (Table 3).
Breast cancer risk factors that have
been investigated as possible explanations
for the racial variation include socioeco-
nomic factors (21,24), reproductive
patterns (25-28), hormones (29-32),
lifestyle (33,35), health care access
(35-37), age (38), proximity or contact
with pesticides (39), diet (40), and genetic
susceptibility (41,42).
One of the earliest analysis of factors
associated with stage at diagnosis for breast
cancer among African American and white
women was conducted by the National
Cancer Institute's African American/White
Cancer Survival Study Group (43). It
assessed in a single study the relationship of
sociodemographic, behavioral, clinicopath-
ologic, and health care access factors to vari-
ations in stage at diagnosis ofbreast cancer
among African American and white partic-
ipants. The results indicated that some fac-
tors associated with stage at diagnosis are
differentially expressed in African Americans
and whites. AmongAfrican Americans only,
the investigators observed that access to
health care, lifestyle, and other antecedent
medical experiences influence disease stage
at diagnosis. These findings suggest that the
advanced stage ofbreast cancer at diagnosis
is related in part to the poorer access to
health care common to socioeconomically
disadvantaged populations.
Addressing essentially the same issue,
Lacey (44) identified several barriers to
breast cancer prevention and early detection
for urban, low-income African American
women, including: a) other urgent life
priorities, b) financial restrictions related
to cost, c) quality of available health
resources, d) limited knowledge regarding
cancer, e) relatively few available sources of
Table 3. Five-year relative survival rates for selected cancers among black and white women, by age group, in the
United States, 1983-1990.
Oral cavity and Colon and Lung and Uterine Urinary Multiple
Age pharynx, % rectum, % bronchus, % Breast, % cervix, % bladder, % myeloma, %
Black women
<45 64.5 55.7 16.4 62.3 68.6 N/A 46.5
45-54 46.5 58.8 13.7 65.9 55.6 N/A 29.3
55-64 49.1 56.7 15.9 66.2 52.4 55.5 33.6
65-74 31.3 46.8 8.3 69.3 47.8 47.6 23.9
>75 30.4 42.3 6.6 67.2 29.7 42.1 19.2
<65 52.1 57.1 15.3 64.7 61.4 54.2 34.6
>65 30.8 45.0 7.8 68.6 40.9 45.3 22.0
White women
<45 85.4 61.0 28.7 78.2 81.1 89.5 47.3
45-54 65.4 61.5 20.7 81.7 68.7 88.7 37.3
55-64 56.5 60.7 17.1 81.4 64.0 83.2 30.6
65-74 52.2 60.4 15.3 83.5 55.1 75.4 25.9
>75 54.5 57.4 10.1 82.2 42.5 62.9 20.7
<65 64.7 60.9 19.0 80.6 75.0 85.3 33.9
>65 53.0 58.9 13.6 83.0 50.5 69.6 23.3
N/A, not available because statistic cannot be calculated due to small numbers. From Reis et al. (3).
information regarding cancer prevention
and detection, andf) poor adherence with
follow-up recommendations. This study
found no evidence that African American
women belonging to lower socioeconomic
classes were disinterested in their health or
less likely than whites to participate in
health promotion activities.
The 5-year survival differences among
women with the same stage disease suggest
that the clinical course ofthe disease is dif-
ferent among African American women
(45). As with other cancers, age modifies
risk, and African American mortality rates
decline below those found among whites
above age 69 (3).
Uterine Cervix
Cancer of the uterine cervix is the third
most common malignancy of the female
reproductive system in the United States
(3). The incidence amongAfricanAmerican
women is approximately twice that found
among white women-14.0 per 100,000
women compared to 7.8 per 100,000
women, respectively (3). This disparity is
evident primarily among women age 65
and over, with African American women
experiencing nearly 3 times the incidence
ofwhite women during the years 1987 to
1991 (41.8 per 100,000 women compared
to 15.3 per 100,000 women) (3). African
American mortality rates (6.7 per 100,000)
have been about 3 times that amongwhites
(2.6 per 100,000), which is also primarily
attributed to the excess incidence ofcervix
cancer among African American women
age 65 and over (3). Between 1973 and
1991, the incidence ofinvasive cervical can-
cer decreased for both African Americans
and whites by 55.1 and 35.4%, respec-
tively. This has not been a steady decline
over the time period, and it has differed by
both race and age. Most of the decline in
the incidence of invasive cervical cancer
observed among white women occurred
during the 1970s and early 1980s. The
decline in incidence has been relatively
steady among African American women,
with some evidence ofa possible slowing or
plateauing in the rate of decrease during
the mid 1980s.
Cervical cancer is generally detected
later among African Americans than
whites. Between 1983 and 1990, 39% of
invasive cervical cancers among African
Americans were detected while the disease
was localized (i.e., confined to the cervix
uteri) compared to 53% for whites (3).
These differences in incidence rates by race
are evidenced among younger and older
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women. In women under 50 years of age,
52% of the invasive cervical cancers
detected in African American women were
diagnosed at the localized stage compared
to 67% among white women. Among
women 50 years ofage and older, 27% of
the invasive cervical cancers diagnosed
among African American women were
localized, as were 36% detected among
white women (3). Five-year survival rates
are lower among African Americans
(56.4%) than whites (69.9%), with little
change over the last two decades (3).
Several factors may have stymied
attempts to reduce these disparities, includ-
ing the failure among women with abnor-
mal Pap smear results to seek follow-up
care. Poor, uninsured, single, and young
women are least likely to follow recom-
mendations regarding follow-up care.
Individuals with abnormal Pap test results
are usually referred to another facility for
treatment. These facilities are often located
farther away than the facility ofinitial diag-
nosis and may necessitate an additional
appointment, which requires the individual
to miss more time at work. Cost may also
act as a barrier. A pelvic examination that
includes a Pap test can cost $100 or more;
a fee that may not be covered by health
insurance plans, which often provide little
preventive coverage.
Sexually transmitted human papilloma
virus infection is the primary risk factor for
most cases of cervical dysplasia and carci-
noma, although other etiologic factors are
probably involved (46). Providing effective
barriers to infection during sexual inter-
course, as well as health education, could
reduce the incidence of cervical cancer
among women of both racial groups.
Improved access to health care may reduce
mortality among African American women
and improve survival rates associated with
this preventable cancer.
Prostate
Prostate cancer is the most commonly diag-
nosed malignancy and the second highest
cause ofcancer-related deaths among men
in the United States, accounting for 32% of
new cancer cases and 13% ofcancer deaths
(Table 1) (3). Prostate cancer is a disease
primarily of older men; it is uncommon
below 55 years ofage. Incidence increases
rapidly with age to more than 1000 cases
per 100,000 individuals among men over
75 years ofage.
Although the incidence and mortality
rates associated with prostate cancer are
higher among African Americans than
whites in the United States, there are wide
variations in the incidence of prostate
cancer among African populations (47).
In Nigeria and the Caribbean, prostate
cancer incidence is much lower than
among African Americans. This suggests
that migration and accompanying changes
in environmental conditions may have
affected prostate cancer risk among
African Americans (48).
Prostate cancer is biologically hetero-
genous in presentation and outcome. It
remains latent in some men but intensively
aggressive in others. The proportion ofearly
curable prostate cancer has increased (49).
In 1990, African American men were more
likely to be diagnosed with stage IV
(29.3%) prostate cancer than white men
(17.8%). African American men had poorer
5-year survival (66.4%) than white men
(81.3%) (3). This corresponded to a greater
prevalence of advanced prostate cancer
among African American men. Whether
this difference could be explained by differ-
ences in urinary obstructive symptoms was
investigated by Brawn et al. (50). They con-
cluded that survival, stratified by stage and
grade, was not affected adverselybyobstruc-
tive symptoms. Neither racial differences in
the incidence ofobstructive symptoms nor
the frequency with which obstructive symp-
toms required surgical correction explain
the later stage at diagnosis found among
African American men. Presentation at a
later stage was almost twice as common
among rural African Americans as among
urban African Americans, suggesting a pos-
sible role for socioeconomic factors and
access to health care (51).
The etiology ofprostate cancer has not
been well characterized and many unre-
solved issues remain. Some investigations
have indicated that individuals with
prostate cancer tend to consume more
dietary animal fat than those not diagnosed
and, therefore, a vegetarian lifestyle may
reduce risk (48). Prostate cancer has also
been linked to a history ofvenereal disease,
having multiple sexual partners, and some
occupations, primarily farming and jobs
involving exposure to cadmium (48). In
one study ofprostate cancer in the south-
eastern United States, farming accounted
for 38% of the geographic difference in
prostate cancer mortality rates among
African Americans (52). Detailed studies
of specific agricultural exposures and
prostate cancer among African American
men have not been conducted to date.
Vasectomy has been identified as a poten-
tial risk factor for prostate cancer in some
studies but not in others (53). In any
event, vasectomy cannot explain the excess
risk among African Americans, because the
prevalence of vasectomy is much lower
among African Americans than whites
(53). Tobacco use does not appear to be
associated with prostate cancer nor does it
explain the racial disparities (54).
A rapidly evolving interest in familiar
aggregation ofprostate cancer has expanded
the base ofevidence supporting family his-
tory as a risk factor for this disease. A hospi-
tal-based study found a 2-fold elevated risk
among men who had a father or brother
with carcinoma of the prostate (55). The
risk increased to 6.1 if both a first-degree
and second-degree relative were affected.
Other studies have noted similar trends of
increasing risk with increasing numbers of
affected relatives. For example, men with
two or three first-degree relatives had a 5-
fold and 11-fold increased risk ofprostate
cancer, respectively, compared with persons
without a family history of the disease
(56-58). Family history and genetic suscep-
tibility may play a role in the racial differ-
ences in incidence rates associated with
prostate cancer.
The higher mortality among African
American men also suggests the role of
other factors in determining stage ofcancer
at diagnosis, such as delay in seeking health
care, demographic variables, socioeco-
nomic status, functional status, and social
support. Among African American men,
there is evidence to link delays in seeking
health care with less favorable disease out-
come. Analysis ofthe Surveillance, Epidemi-
ology and End Results (SEER) program
data from Detroit shows that increases in
cancer detection were less among African
American men at the same time that
increases in detection trends were being
recorded for other segments ofthe popula-
tion (59). Similar evidence was found in
the 1990 National Cancer Data Base
report (49), where there were large differ-
ences in the proportion of advanced can-
cers diagnosed among African American
and white men. The authors concluded
that "Regrettably, not all segments of the
population at risk are benefiting from early
detection ofprostate cancer."
Bladder
Urinary bladder cancer accounts for 78,800
new cases and 21,900 deaths each year in
the United States (3). African Americans
have lower incidence ofbladder cancer than
whites (Table 1), but the 5-year relative
survival is lower among African Americans
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Table 4. Five-year relative survival rates for selected cancers among black and white men by age group, in the
United States, 1983-1990.
Oral cavity and Colon and Lung and Urinary Multiple
Age pharynx, % rectum, % bronchus, % bladder, % Prostate, % myeloma, %
Black men
<45 33.6 47.8 11.4 85.3 27.8
45-54 31.0 51.1 10.5 70.9 66.5 38.7
55-64 25.3 53.2 11.9 69.2 67.7 39.1
65-74 25.4 49.5 10.8 65.0 70.7 26.5
275 18.8 38.0 5.5 47.8 57.8 20.1
<65 29.2 51.6 11.4 72.6 67.3 37.3
>65 24.8 45.6 9.5 59.1 66.0 24.1
White men
<45 54.0 54.1 18.8 93.0 70.0 45.8
45-54 54.3 60.7 14.5 89.0 77.3 44.1
55-64 49.8 61.3 13.5 85.6 82.3 34.1
65-74 52.3 62.6 11.4 82.4 84.9 25.0
275 57.9 58.0 7.9 73.0 76.2 13.3
<65 51.8 60.4 14.1 87.3 81.6 37.7
>65 53.9 60.9 10.3 79.0 81.2 20.5
From Reis et al. (3).
diagnosed with this type of cancer than
among whites (Tables 3,4). The higher
incidence among whites is primarily due to
excess localized tumors, whereas the inci-
dence of more advanced tumors is similar
among both racial groups (60). These data
suggest that whites are more likely to be
diagnosed with conditions that go unde-
tected among African Americans and are
less likely to progress to more extensive dis-
ease. Among both African Americans and
whites in one large case-control study,
smoking accounted for most ofthe bladder
cancer risk (48 and 43%, respectively)
(60). Workers in high-risk occupations
involving exposure to dyes, rubber, leather,
ink, or paints accounted for 22% ofcases
among African Americans and 28% of
cases among whites. History of bladder
infection was linked to approximately twice
as much disease among African Americans
as whites (15% compared to 8%).
Multiple Myeloma
There are approximately 12,700 new cases
and 9800 deaths from multiple myeloma
annually in the United States (Table 1) (3).
The incidence and mortality of multiple
myeloma are approximately 2-fold greater
among African Americans than whites.
With a largely unknown etiology and the
highest world-wide incidence rates occur-
ring among African American African
descendants, investigators struggle to iden-
tify risk factors (61). Studies of occupa-
tional exposures (62), human leukocyte
antigens (63), and chronic antigenic stimu-
lation (64) have not been found to explain
the disparities between African Americans
andwhites.
Conclusion
Available data suggest that there continue
to be differences by race in the incidence
and mortality for common types ofcancers.
Studies of these patterns suggest etiologic
factors and have led to the identification of
probable causes. These factors, however,
generally fail to satisfactorily explain the
racial differences in incidence and mortality
rates. This may be due to the inappropriate
use of race and ethnicity as surrogates for
social and economic status. It may be easier
to use race as a surrogate for social and eco-
nomic status than to identify a person of
color who has limited resources, lives in a
substandard residential environment,
works in a high-risk occupational setting,
or is a single parent exposed to multiple
risk factors-psychological, physiological,
or both. Focusing on the poor surrogate of
race, however, may limit the sensitivity of
our research.
There are racial biologic variations and
within-race individual differences, both
inherited and acquired. These differences
may modify various phases of the multi-
stage process ofcarcinogenesis such as the
capacity to convert procarcinogens to car-
cinogens, to detoxify carcinogens, and to
repair DNA. Future progress in untangling
the multifactorial dimensions ofAfrican
American/white differences in cancer
burden must move beyond traditional epi-
demiologic methods. Cancer risk char-
acterization must include more emphasis
on biological evaluation ofqualitative inter-
individual differences in susceptibility. This
approach can be enhanced by significant
advances that have been achieved in the
molecular, genetic, and biologic aspects of
the more common types ofcancers.
The intense activity of those studying
the molecular and genetic aspect ofhuman
cancer undoubtedly will generate further
advances in the identification and charac-
terization ofcancer risk. Thus, it does not
seem overly optimistic to suggest that
approaches that combine clinical, epidemi-
ological, and molecular research ultimately
will illuminate more clearly the primary
and secondary determinants of racial/eth-
nic differences in cancer incidence and
mortality. The results of this research in
conjunction with lifestyle changes, socioe-
conomic parity, and environmental equity,
has the potential to bring about the most
effective prevention and control strategies
to relieve African Americans oftheir dis-
proportionate share ofthe cancer burden.
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